TipRanks
Eloxx Pharmaceuticals (ELOX)
NASDAQ:ELOX
US Market
ELOX
Eloxx Pharmaceuticals
RESEARCH TOOLSreports
Want to see ELOX full AI Analyst Report?

Eloxx Pharmaceuticals (ELOX) Income Statement

308 Followers

Eloxx Pharmaceuticals Income Statement

Last quarter (Q2 2026), Eloxx Pharmaceuticals's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q2, Eloxx Pharmaceuticals's net income was $-4.50M. See Eloxx Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Mar 23Mar 22
Total Revenue
$ 0.00$ 6.36M$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ 6.36M$ 0.00$ -695.00K$ -960.00K
Operating Expenses
$ 6.44M$ 8.83M$ 17.29M$ 33.72M$ 41.39M
Depreciation and Amortization
$ 0.00$ 164.00K$ 809.00K$ 695.00K$ 960.00K
EBITDA
$ -4.95M$ -1.83M$ -15.09M$ -33.50M$ -64.51M
Operating Income
$ -6.44M$ -2.47M$ -17.29M$ -34.42M$ -42.35M
Other Income/Expenses
$ 443.00K$ -675.00K$ 234.00K$ -1.72M$ -24.38M
Pretax Income
$ -6.00M$ -3.14M$ -17.05M$ -36.14M$ -66.73M
Net Income
$ -6.00M$ -3.14M$ -17.05M$ -36.06M$ -66.73M
Per Share Metrics
Basic EPS
$ -5.34$ -9.24$ -72.93$ -183.13$ -419.65
Diluted EPS
$ -5.34$ -9.24$ -72.93$ -183.13$ -419.65
Weighted Average Shares Outstanding
 1.12M 341.71K 233.69K 196.94K 159.01K
Weighted Average Shares Outstanding (Diluted)
 1.12M 341.71K 233.69K 196.94K 159.01K
Currency in USD

Eloxx Pharmaceuticals Earnings and Revenue History